CG Oncology Stock Signals Bullish Momentum Ahead

CG Oncology (NASDAQ:CGON) has moved into Phase 2 of its 18-phase Adhishthana cycle, a critical stage that often sets the tone for early bullish momentum. Within this phase, the stock transitions into what’s called the Buddhi move period, where breakouts are more likely to unfold. Here’s how the stock is structured under the lens of the Adhishthana Principles and what investors should watch for next.

Read the full article on Benzinga for deeper insights into the Adhishthana Cycle, the stock’s recent trajectory, and expert commentary.